Hints and tips:
Related Special Reports
US biotech has been struggling to overcome fall in demand for coronavirus jabs
Companies have yet to provide investors with convincing post-pandemic strategies
...These schemes help restore native forest and create economic opportunities for local communities, Apple adds. But critics have cast doubt on these plans....
...Avid Bioservices, a small-cap company that helps develop and manufacture drugs for pharmaceutical companies, filed this with the SEC yesterday: On February 29, 2024, Avid Bioservices, Inc....
...They objected to its location in a water conservation zone bordering on a nature reserve and to the fact that hundreds of hectares of forest had to be cleared to make way for the factory....
...2022, has been controversial among environmental campaigners and locals, who two weeks ago overwhelmingly voted against a major expansion plan that would have involved clearing hundreds of hectares of forest...
...Abel have been watching as billions of dollars of liabilities accumulate at Berkshire’s energy division, where its largest electric utility is wrestling with legal proceedings over its alleged role in forest...
...The Medicines and Healthcare products Regulatory Agency has approved the therapy, called Casgevy, which was developed by Vertex Pharmaceuticals and Crispr Therapeutics....
...Despite splashing out nearly $55bn on two major acquisitions over the past two years, the pharmaceutical company is worth less than it was before the pandemic....
US drugmaker is trying to chart its future without blockbuster Covid-19 products
Millions of Paxlovid pills have gone unused as tight controls restrict access
...Rival pharmaceutical groups are eager to enter the market, including AstraZeneca, which recently signed a licensing deal with Chinese company Eccogene for the rights to its weight loss pill....
Doubts grow over safety and effectiveness of drugs that were marketed as coronavirus treatments
...At one point pharmaceutical company Pfizer even set out a “no jerks” policy....
Investor worries about the impact of weight loss drugs on food companies are overdone
...Teresa Graham, chief of Roche’s pharmaceutical division, said more patients suffered from diseases of the immune system than from cancer, and the current drugs did not serve them well....
...His holding company managed a sprawling portfolio that included billion-dollar-plus stakes in companies such as Apple, Netflix, Forest Labs and Herbalife, while he was plotting bids to take over Clorox and...
Biotech group hit by lower demand, with majority of write-offs relating to raw materials bought during pandemic
Rare step comes after Brussels fined US biotech for buying Grail without approval
...The UK pharmaceutical retailer’s transfer of £4.8bn of pension obligations to insurer Legal & General brings its potential sale by owner Walgreens Boots Alliance one step closer....
Biotech has been criticised for closing its $8bn acquisition of cancer test company Grail without regulatory approval
...The Swiss pharmaceuticals group is following many rivals to focus its operations on higher-value innovative treatments rather than the cheaper off-patent drugs made by Sandoz, including generic versions...
...He said chancellor Jeremy Hunt and the health department should address conflicts with the pharmaceutical industry over drug prices and hurdles to running clinical trials in the NHS....
...The settlement resolves the Federal Trade Commission’s first challenge to a pharmaceutical deal in more than a decade....
...But Amyris had also branched out into being an incubator for beauty start-ups including Rose Inc, Costa Brazil and JVN hair care, and it proved too huge a leap from developing molecules to developing brands...
International Edition